D-0865-2016 Class I Ongoing

Recalled by Hospira Inc. — Lake Forest, IL

FDA drug recall D-0865-2016 was initiated by Hospira Inc. on Mar 18, 2016 and is designated Class I. Reason for recall: Presence of Particulate Matter: particulate matter identified as an insect in one vial. The recall status is ongoing. Affected quantity: 72,000 units.

Recall details

Product Type
Drugs
Report Date
Jun 1, 2016
Initiation Date
Mar 18, 2016
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
72,000 units

Product description

8.4% Sodium Bicarbonate Injection, USP 50mEq (1mEq/mL), 4.2 grams (84 mg/mL), 50 mL, Rx only, Hospira Inc, Lake Forest, IL 60045, NDC 0409-6625-02

Reason for recall

Presence of Particulate Matter: particulate matter identified as an insect in one vial.

Distribution pattern

Nationwide

Code information

Lot # 56-148-EV, Exp 8/1/2017

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0865-2016
openFDA file date
Nov 19, 2026
Loaded by RegDataLab
Nov 20, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Need the full FDA record for Hospira Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: openFDA record for D-0865-2016. Report a data issue: hello@regdatalab.com.